Dr David Jiang
Dr. Jiang is a corporate strategy and business development executive with broad industry experience in pharmaceutical and diagnostics companies. In his current role as Managing Director of BIOCOM China Consulting, Dr. Jiang is advising and assisting U.S. and Chinese pharmaceutical and biotech companies to establish partnerships in research, development, clinical trials and commercialization. Before joining BIOCOM, he led a team that helped Gen-Probe develop a corporate strategic plan and complete their first major acquisition in Europe. Dr. Jiang was also a fully licensed equity research analyst at Bear Stearns.
Dr. Jiang has a decade of China commercial planning experience. While at Gen-Probe, he developed their China entry strategies and twice accompanied the CEO for executive level partnership discussions in China. As an Associate Director of Wyeth’s Asia Pacific Commercial Operations, he led the strategic planning effort of their $1.3 billion business.
Dr. Jiang graduated Phi Beta Kappa from Grinnell College. He earned his Ph.D. in Cellular and Molecular Medicine from the Johns Hopkins University School of Medicine. In addition, Dr. Jiang holds an MBA with national honors from Emory University.